Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1655-1663

  Iwagaki, Akitaka ^a   Porro, Massimo ^b   Pollack, Matthew ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b BiosYnth Research Laboratories   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G2A; INTERLEUKIN 6; LIPID A; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYMYXIN B; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CHO CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DETOXIFICATION; DRUG POTENTIATION; FLOW CYTOMETRY; GRAM NEGATIVE SEPSIS; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR MIMICRY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; CHO CELLS; CRICETINAE; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICROSCOPY, CONFOCAL; OLIGOPEPTIDES; PEPTIDES; PEPTIDES, CYCLIC; POLYMYXIN B;

EID: 0033975319     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1655-1663.2000     Document Type: Article

References (38)

1. Coyne, C. P., and B. W. Fenwick. 1993. Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor-α synthesis by polymyxin B sulfate. Am. J. Vet. Res. 54:305-314.
2. Demitri, M. T., M. Velucchi, L. Bracci, A. Rustici, M. Porro, P. Villa, and P. Ghezzi. 1996 Inhibition of LPS-induced systemic and local TNF production by a synthetic anti-endotoxin peptide (SAEP-2). J. Endotoxin Res. 3:445-454.
3. Di Padova, F. E., H. Brade, G. R. Barclay, I. R. Poxton, E. Liehl, E. Schuetze, H. P. Kocher, G. Ramsay, M. H. Schreier, D. B. McClelland, and E. T. Rietschel. 1993. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharide. Infect. Immun. 61:3863-3872.
4. Evans, T. J., A. Carpenter, D. Moyes, R. Martin, and J. Cohen. 1995. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis. J. Infect. Dis. 171:153-160.
5. Golenbock, D. T., Y. Liu, F. H. Millham, M. W. Freeman, and R. A. Zoeller. 1993. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J. Biol. Chem. 268:22055-22859.
6. Hegemann, L., L. A. A. van Rooijen, J. Traber, and B. H. Schmidt. 1991. Polymyxin B is a selective and potent antagonist of calmodulin. Eur. J. Pharmacol. 207:17-22.
7. Heumann, D., P. Gallay, C. Barras, P. Zaech, R. J. Ulevitch, P. S. Tobias, M.-P. Glauser, and J. D. Baumgartner. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148:3505-3512.
8. Jun, C.-D., B.-M. Choi, H.-M. Kim, and H.-T. Chung. 1995. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages. J. Immunol. 154:6541-6547.
9. Kirkland, T. N., F. Finley, D. Leturcq, A. Moriarty, J.-D. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268:24818-24823.
10. Kiss, Z., E. Deli, P. Girard, R. Pettit, and J. Kuo. 1987. Comparative effects of polymyxin B, phorbol ester and bryostatin on protein phospholylation, protein kinase C translation, phospholipid metabolism and differentiation of HL60 cells. Biochem. Biophys. Res. Commun. 146:208-215.
11. Kitchens, R. L., R. J. Ulevitch, and R S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485-494.
12. Landmann, R., C. Ludwig, R. Obrist, and J. P. Obrecht. 1991. Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages. J. Cell. Biochem. 47:317-329.
13. Marra, M. N., J. Au-Young, L. Lin, J. C. Lane, J. L. Snable, M. B. Thornton, B. M. McKelligon, J. J. Seilhamer, and R W. Scott. 1994. Identification of bactericidal/permeability increasing protein (BPI) and lipopolysaccharide binding protein (LBP) domains which are important for LPS neutralizing or transducing activity and circulating half-life. J. Endotoxin Res. 1(Suppl. 1):18.
14. Martin, T. R., J. C. Mathison, P. S. Tobias, D. J. Leturcq, A. M. Moriarty, R. J. Maunder, and R. J. Ulevitch. 1992. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J. Clin. Investig. 90:2209-2219.
15. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818.
16. Naccache, P., M. Molski, and R. Sha'afi. 1985. Polymyxin B inhibits phorbol 12-myristate 13-acetate, but not chemotactic factor, induced effects in rabbit neutrophils. FEBS Lett. 192:227-230.
17. Natanson, C., and J. E. Parrillo. 1988. Septic shock. Anesthesiol. Clin. N. Am. 6:73-85.
18. Parrillo, J. E. 1989. Septic shock in humans: clinical evaluation, pathogenesis, and therapeutic approach, p. 1006-1024. In W. C. Shoemaker, S. Anres, A. Grenvik, et al. (ed.), Textbook of critical care. W. B. Saunders Co., Philadelphia, Pa.
19. Pedersen, M. R., S. Jensen, J. D. Christensen, and E. W. Hansen. 1995. Lipopolysaccharide in concentrations above 40 ng/ml stimulates proliferation of the IL-6-dependent B9 cell line. J. Immunol. Methods 180:159-163.
20. Pollack, M., A. M. Espinoza, G. Guelde, N. L. Koles, L. M. Wahl, and C. A. Ohl. 1995. Lipopolysaccharide (LPS)-speclfic monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-α responses by human monocytes. J. Infect. Dis. 172:794-804.
21. Pollack, M., C. A. Ohl, D. T. Golenbock, F. DiPadova, L. M. Wahl, N. L. Koles, G. Guelde, and B. G. Monks. 1997. Dual effects of lipopolysaccharide (LPS) antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions. J. Immunol. 151:3519-3530.
22. Porro, M. 1994. Structural basis of endotoxin recognition by natural polypeptides. Trends Microbiol. 2:65-67.
23. Porro, M. 1994. Cyclic or linear conformations of sequences binding lipid A: does it really matter? Trends Microbiol. 2:338-339.
24. Rietschel, E. T., T. Kirikae, F. U. Schade, A. J. Ulmer, O. Holst, H. Brade, G. Schmidt, U. Mamat, H.-D. Grimmecke, S. Kusumoto, and U. Zähringer. 1993. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187:169-190.
25. Roth, R. I., and P. S. Tobias. 1993. Lipopolysaccharide-binding proteins of Limulus amebocyte lysate. Infect. Immun. 61:1033-1039.
26. Ruff, M., and G. Gifford. 1980. Purification and physicochemical characterization of rabbit tumor necrosis factor. J. Immunol. 125:1671-1677.
27. Rustici, A., M. Velucchi, R. Faggioni, M. Sironi, P. Ghezzi, S. Quataert, B. Green, and M. Porro. 1993. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science 259:361-365.
28. Skelly, R. R., P. Munkenbeck, and D. C. Morrison. 1979. Stimulation of T-independent antibody responses by hapten-lipopolysaccharides without repeating polymeric structure. Infect. Immun. 23:287-293.
29. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482-10488.
30. Tobias, P. S., and R. J. Ulevitch. 1993. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 187: 227-232.
31. Ulevitch, R. J. 1999. Endotoxin opens the Tollgates to innate immunity. Nat. Med. 5:144-145.
32. Vaara, M., and M. Porro. 1996. Group of peptides that act synergistically with hydrophobic antibodies against gram-negative enteric bacteria. Antimicrob. Agents Chemother. 40:1801-1805.
33. Viriyakosol, S., and T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361-368.
34. Wahl, S. M., N. McCartney-Francis, D. A. Hunt, P. D. Smith, L. M. Wahl, and I. M. Katona. 1987. Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J. Immunol. 139; 1342-1347.
35. Warren, H. S., M. L. Glennon, N. Wainwright, S. F. Amato, K. M. Black, S. J. Kirsch, G. R. Riveau, R. I. Whyte, W. M. Zapol, and T. J. Novitsky. 1992. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect. Immun. 60:2506-2513.
36. Wright, S. D. 1999. Toll, a new piece in the puzzle of innate immunity. J. Exp. Med. 189:605-609.
37. Wright, S. D., R A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
38. Zhang, G. H., D. M. Mann, and C. M. Tsai. 1999. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 67:1353-1358.